What is the Historic and Current Scenario of the Heart Attack Diagnostic Market?
The heart attack diagnostic market has seen considerable growth due to a variety of factors.
• In the past few years, there has been a robust growth in the market size of heart attack diagnostics. The market is expected to expand from $10.78 billion in 2024 to $11.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to the growth during the historic period include the advancement in cardiac biomarkers, the advent of ECG and imaging technology, standardization of diagnostic procedures, initiatives that raise awareness and educate, and enhancements in troponin testing.
What Is The Expected Growth In The Heart Attack Diagnostic Template Market?
The Heart Attack Diagnostic market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for diagnosing heart attacks is predicted to witness robust expansion in the forthcoming years, increasing to $16.49 billion by 2029 with a compound annual growth rate (CAGR) of 9.2%.
The projected growth for the stipulated period is due to factors such as patient involvement and engagement, use of data analytics and precision medicine, initiatives for preventive healthcare, development of healthcare infrastructure, and personalized diagnostic methods. Some of the key trends anticipated during this forecast period are testing at the point-of-care, high-sensitivity troponin tests, non-invasive imaging procedures, customized medicine, and devices for remote monitoring.
What Main Forces Are Fueling Expansion In The Heart Attack Diagnostic Market?
The increasing occurrence of heart-related diseases is catalyzing the expansion of the market for heart attack diagnostics. Cardiovascular disorders, made up of various ailments related to heart and blood vessels, are being intensified by unhealthy eating habits, lack of physical activity, tobacco consumption, and alcohol abuse, all of which contribute to heart diseases and strokes. Diagnosing heart attacks is an essential process that determines the severity and cause of heart attacks, strokes, and heart failure. For example, data released from the UK's Office for Health Improvement and Disparities in March 2024 showed that in 2023, over 1,862,500 people (3%) in England had been diagnosed with coronary heart disease (CHD) by a General Practitioner. Therefore, as incidents of cardiovascular diseases continue to rise, so will the growth of the heart attack diagnostics market.
What Are The Primary Segments In The Global Heart Attack Diagnostic Market?
The heart attack diagnostic market covered in this report is segmented –
1) By Test Type: Electrocardiogram (ECG Or EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
Subsegments:
1) By Electrocardiogram (ECG Or EKG): Resting ECG, Holter Monitor, Event Monitor
2) By Blood Tests: Cardiac Biomarkers, Lipid Panel, B-Type Natriuretic Peptide (BNP)
3) By X-Ray: Chest X-Ray, Angiography X-Ray
4) By Echocardiogram: Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Doppler Echocardiogram
5) By Coronary Catheterization (Angiogram): Coronary Angiography, Right Heart Catheterization, Left Heart Catheterization
6) By Exercise Stress Test: Treadmill Stress Test, Pharmacologic Stress Test, Nuclear Stress Test
7) By Magnetic Resonance Imaging (MRI): Cardiac MRI, Stress MRI, Perfusion MRI
Pre-Book The Heart Attack Diagnostic Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Heart Attack Diagnostic Market?
The emergence of innovative diagnostic methods for heart disease is a prominent trend in the heart diagnostic market. Key industry players are pioneering new technologies such as artificial intelligence to diagnose heart disease. Artificial intelligence, which mimics human thinking in machines designed to behave like humans, is used to enhance diagnostic radiography skills, diagnose heart issues, and expedite stroke treatments. For instance, in February 2022, Physician-scientists from the Smidt Heart Institute at Cedars-Sinai, a nonprofit academic healthcare institution, created an AI-based technique to detect difficult-to-diagnose heart conditions. The AI system is able to recognise disease patterns that are undetectable to the human eye, and uses these patterns to predict accurate diagnoses. Conditions such as hypertrophic cardiomyopathy and cardiac amyloidosis, both potentially lethal, are effectively identified and differentiated by artificial intelligence technology.
Who Are the Key Players In The Heart Attack Diagnostic Market?
Major companies operating in the heart attack diagnostic market include:
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• General Electric Co.
• Hitachi Ltd.
• Koninklijke Philips NV
• Midmark Corp.
• Siemens AG
• Toshiba Corp.
• Welch Allyn Inc.
• HILL ROM HOLDINGS Inc.
• Canon Medical Systems Corporation
• Bio-Rad Laboratories Inc.
• Fujifilm Holdings
• ACS Diagnostics Inc.
• Beckman Coulter Inc.
• Schiller AG
• GE Healthcare
• HeartFlow
• Medtronic PLC
• Cardio Diagnostics Holdings Inc.
• Becton Dickinson and Company
• Danaher Corporation
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Quest Diagnostics
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
What Is The Most Dominant Region In The Heart Attack Diagnostic Market?
North America was the largest region in the heart attack diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
